Alexander Nowak

Stock Analyst at Craig-Hallum

(1.75)
# 1293
Out of 5,270 analysts
59
Total ratings
50.00%
Success rate
20.42%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
CVRx
Maintains: Strong Buy
20 22
12.34 78.28% 5 Jan 17, 2025
Natera
Maintains: Strong Buy
121 157
143.16 9.67% 4 Nov 13, 2024
Bioventus
Maintains: Strong Buy
12 17
10.13 67.82% 6 Sep 27, 2024
QuidelOrtho
Upgrades: Buy
40 57
39.07 45.89% 6 Sep 5, 2024
Celcuity
Assumes: Buy
25 27
8.95 201.68% 2 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 15
21.14 -29.04% 3 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
8
6.28 27.39% 4 Apr 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.03 -2.91% 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
1
n/a n/a 2 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
2
n/a n/a 2 Oct 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
8.27 117.65% 1 Sep 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
74 50
20.75 140.96% 2 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 8
0.65 1130.77% 1 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
96 36
n/a n/a 3 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Mar 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
1.96 461.22% 1 Jan 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
8 3
n/a n/a 2 Nov 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 28
n/a n/a 2 Jul 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
88 110
61.24 79.62% 2 Feb 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jan 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
300
3.26 9102.45% 1 Jan 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
7.26 285.67% 1 Aug 31, 2020